Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets:
Cash and cash equivalents	$ 66,929	$ 51,582
Accounts receivable, net	130,889	71,382
Inventory	37,108	25,181
Prepaid expenses and other current assets	7,570	7,987
Total current assets	242,496	156,132
Non-current assets:
Capitalized software development costs, net	74,463	93,079
Intangible assets, net	1,414,192	1,432,221
Total assets	1,731,151	1,681,432
Current Liabilities:
Accounts payable	164,299	78,907
Other current liabilities	230,967	196,590
Loans payable, current portion	494,527	546,052
Convertible notes payable	1,223,500	1,235,500
Total current liabilities	2,113,293	2,057,049
Total liabilities	2,113,293	2,057,049
Commitments and contingencies (Note 13)
Stockholders’ Deficit:
Common stock, 900,000,000 shares authorized, $0.0001 par value; 10,215,508 and 9,735,508 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively	1,022	974
Additional paid-in capital	3,618,247	3,606,295
Accumulated deficit	(4,001,783)	(3,983,258)
Total stockholders’ deficit	(382,142)	(375,617)
Total liabilities and stockholders’ deficit	1,731,151	1,681,432
Series A Preferred Stock [Member]
Stockholders’ Deficit:
Preferred stock, value	108	108
Series A-2 Preferred Stock [Member]
Stockholders’ Deficit:
Preferred stock, value	$ 264	$ 264